fundvisualizer.com

AXS Alternative Value InvestorCOGLX

Performance (before sales charge)

As of 02/29/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
108.10%
Non-U.S. Stock
1.81%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
-9.83%
Other
-0.08%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

0.00%

Consumer cyclical

6.95%

Financial services

16.71%

Real estate

1.48%

Consumer defensive

26.58%

Health care

31.45%

Utilities

2.32%

Communication services

4.60%

Energy

1.39%

Industrials

10.67%

Technology

7.76%

Top 10 holdings

As of 12/31/2023

Bnp Borrowing
10.64%
Akamai Technologies Inc
1.80%
Costco Wholesale Corp
1.74%
Vertex Pharmaceuticals Inc
1.73%
Cardinal Health Inc
1.69%
International Business Machines Corp
1.67%
Molina Healthcare Inc
1.66%
Republic Services Inc
1.65%
Amgen Inc
1.64%
Regeneron Pharmaceuticals Inc
1.63%
Fund assets

$13.15 Million

Share class

Inv

Morningstar category

Large Value

Expense ratio

2.68%

Investment objective

Growth

Documents